ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

Professional Societies: Organizations Form Alliance To Call For Quality Cancer Care

October 9, 1998

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

RFAs available: Chemoprevention Clinical Trials

July 22, 1994

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997